0000899243-18-002006.txt : 20180125
0000899243-18-002006.hdr.sgml : 20180125
20180125192831
ACCESSION NUMBER: 0000899243-18-002006
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180125
FILED AS OF DATE: 20180125
DATE AS OF CHANGE: 20180125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koppel Adam
CENTRAL INDEX KEY: 0001578965
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 18549583
MAIL ADDRESS:
STREET 1: C/O BROOKSIDE CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON ST
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences, LLC
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 900943402
BUSINESS ADDRESS:
STREET 1: 161 FIRST STREET, THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-337-4682
MAIL ADDRESS:
STREET 1: 161 FIRST STREET, THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-01-25
0
0001707502
Solid Biosciences, LLC
SLDB
0001578965
Koppel Adam
C/O BAIN CAPITAL LIFE SCIENCES INVESTORS
LLC, 200 CLARENDON STREET
BOSTON
MA
02116
1
0
0
0
Common Stock
1689444
I
See Footnotes
Represents shares held directly by BCLS SB Investco, LP ("BCLS").
The governance, investment strategy and decision-making process with respect to investments held by BCLS is directed by Bain Capital Life Sciences Investors, LLC, whose managers are Jeffrey Schwartz and Adam Koppel. By virtue of the relationships described in these footnotes, Dr. Koppel may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by BCLS. Dr. Koppel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Adam Koppel
2018-01-25